doi: 10.1016/s0140-6736(95)91857-4.
HIV-1, the brain, and combination therapy
Affiliations
- PMID: 7475712
- DOI: 10.1016/s0140-6736(95)91857-4
Item in Clipboard
HIV-1, the brain, and combination therapy
Lancet.
.
No abstract available
Similar articles
-
New developments in antiretroviral drug therapy for HIV-1 infections.AIDS Clin Rev. 1995-1996:305-46. AIDS Clin Rev. 1995. PMID: 7488558 Review. No abstract available.
-
Neurological efficacy of stavudine, zidovudine, and lamivudine.Lancet. 1998 Aug 1;352(9125):402. doi: 10.1016/S0140-6736(05)60498-9. Lancet. 1998. PMID: 9717950 No abstract available.
-
FDA triple header. Food and Drug Administration.GMHC Treat Issues. 1995 Nov;9(11):1-3. GMHC Treat Issues. 1995. PMID: 11362986
-
Update on clinical trials of combination therapies for HIV infection.NIAID AIDS Agenda. 1995 Sep:8. NIAID AIDS Agenda. 1995. PMID: 11362803
-
An approach to antiretroviral treatment of HIV disease. Nucleoside monotherapy.Hosp Pract (1995). 1995 Aug;30 Suppl 1:5-22. Hosp Pract (1995). 1995. PMID: 7635917 Review.
Cited by
-
Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.Drugs. 1997 Jun;53(6):1054-80. doi: 10.2165/00003495-199753060-00009. Drugs. 1997. PMID: 9179531 Review.
-
Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.AJNR Am J Neuroradiol. 2001 Feb;22(2):277-83. AJNR Am J Neuroradiol. 2001. PMID: 11156769 Free PMC article.
-
Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):34-41. doi: 10.1136/jnnp.65.1.34. J Neurol Neurosurg Psychiatry. 1998. PMID: 9667558 Free PMC article.
-
Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences.Drugs. 1996 Aug;52(2):168-85. doi: 10.2165/00003495-199652020-00002. Drugs. 1996. PMID: 8841736
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
